10.1002/jso.2930240119
10.1056/NEJM199112053252301
10.1200/JCO.2003.07.127
10.1097/00000421-200308002-00009
10.1023/A:1026387908165
10.1111/j.1464-410X.2004.04601.x
10.1038/newbio231232a0
10.1002/(SICI)1098-1128(199603)16:2<181::AID-MED3>3.0.CO;2-X
10.1016/S0006-2952(97)00342-0
10.1096/fasebj.12.12.1063
10.1124/pr.56.3.3
10.1016/0016-5085(94)90246-1
10.1093/jnci/90.6.455
Okami J, 1999, Overexpression of cyclooxygenase‐2 in carcinoma of the pancreas, Clin Cancer Res, 5, 2018
Tucker ON, 1999, Cyclooxygenase‐2 expression is up‐regulated in human pancreatic cancer, Cancer Res, 59, 987
Hida T, 1998, Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas, Cancer Res, 58, 3761
Cohen EG, 2003, Microsomal prostaglandin E synthase‐1 is overexpressed in head and neck squamous cell carcinoma, Clin Cancer Res, 9, 3425
10.1038/nm0302-289
Mutoh M, 2002, Involvement of prostaglandin E receptor subtype EP(4) in colon carcinogenesis, Cancer Res, 62, 28
10.1016/S0092-8674(00)81433-6
10.1023/A:1026575610124
10.1074/jbc.M107829200
10.2174/1381612043453117
Huang M, 1996, Non‐small cell lung cancer‐derived soluble mediators and prostaglandin E2 enhance peripheral blood lymphocyte IL‐10 transcription and protein production, J Immunol, 157, 5512, 10.4049/jimmunol.157.12.5512
10.1054/drup.2001.0219
10.1136/jcp.55.6.429
10.1093/jnci/djj206
10.1146/annurev.med.57.121304.131253
10.2174/0929867003374336
10.2174/1568009043481632
10.4161/cbt.3.1.571
Narayanan BA, 2003, Suppression of N‐methyl‐N‐nitrosourea/testosterone‐induced rat prostate cancer growth by celecoxib: effects on cyclooxygenase‐2, cell cycle regulation, and apoptosis mechanism(s), Clin Cancer Res, 9, 3503
10.1096/fj.01-0299fje
10.1016/j.bcp.2003.12.014
Hung WC, 2000, Induction of p27(KIP1) as a mechanism underlying NS398‐induced growth inhibition in human lung cancer cells, Mol Pharmacol, 58, 1398, 10.1124/mol.58.6.1398
10.1124/mol.62.6.1515
Waskewich C, 2002, Celecoxib exhibits the greatest potency amongst cyclooxygenase (COX) inhibitors for growth inhibition of COX‐2‐negative hematopoietic and epithelial cell lines, Cancer Res, 62, 2029
Nam DH, 2004, Intracranial inhibition of glioma cell growth by cyclooxygenase‐2 inhibitor celecoxib, Oncol Rep, 11, 263
10.1016/S0145-2126(03)00183-8
10.1002/ijc.20878
Chang HC, 2001, Cyclooxygenase‐2 level and culture conditions influence NS398‐induced apoptosis and caspase activation in lung cancer cells, Oncol Rep, 8, 1321
Jazirehi AR, 2004, Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non‐Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel‐induced apoptosis, Mol Cancer Ther, 3, 71, 10.1158/1535-7163.71.3.1
10.1053/jhep.2002.36125
10.1023/A:1020224503335
10.1016/S0006-291X(02)02707-9
10.1023/A:1006728119549
10.1053/j.seminoncol.2004.03.040
10.1038/sj.bjc.6600815
10.1038/sj.emboj.7600501
10.1002/jcp.10178
10.1006/scbi.1996.0020
10.1002/jcp.10142
10.1126/science.277.5323.225
10.1053/jhep.2002.32676
10.1074/jbc.M202334200
10.1016/j.cellsig.2008.02.004
10.1110/ps.8.8.1636
10.1038/nrc745
10.1182/blood.V89.5.1708
10.1073/pnas.95.22.13221
10.1038/sj.onc.1206017
10.3181/0709-RM-257
10.1002/jcb.20091
10.1158/1535-7163.MCT-05-0213
10.1093/hmg/ddm018
